Nilotinib-Induced Acute Interstitial Nephritis during the Treatment of Chronic Myeloid Leukemia
Tyrosine kinase inhibitors (TKIs) are targeted therapy drugs that selectively inhibit protein kinases. Nephrotoxicity associated with TKIs is uncommon. We report a case of a 39-year-old man with acute kidney injury that developed after nilotinib treatment for chronic myeloid leukemia (CML). The rena...
Main Author: | Min Jeong Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Kosin University College of Medicine
2021-12-01
|
Series: | Kosin Medical Journal |
Subjects: | |
Online Access: | http://www.kosinmedj.org/upload/pdf/kmj-36-2-153.pdf |
Similar Items
-
Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients
by: Zaidi U, et al.
Published: (2019-02-01) -
The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patient: a literature review
by: Muhammad Darwin Prenggono, et al.
Published: (2021-11-01) -
Acute interstitial nephritis induced by Solanum nigrum
by: Sung Sik Oh, et al.
Published: (2016-12-01) -
Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia
by: N. A. Avxentyev, et al.
Published: (2018-08-01) -
Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)